Interesting facts
Interesting Facts about 3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one
3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one is a fascinating organic compound that has garnered interest in the fields of medicinal chemistry and pharmaceuticals. This compound is known for its intriguing structural features and potential applications. Here are some noteworthy aspects:
- Pharmacological Potential: This compound has been studied for its possible biological activities, including anti-inflammatory and antioxidant properties. Such activities make it a candidate for the development of novel therapeutic agents.
- Complex Structure: The presence of both the furan ring and sulfonyl group in its structure adds to its chemical versatility, allowing for a range of reactions, which could lead to a variety of derivatives with tailored properties.
- Research Applications: Due to its unique structural characteristics, this compound is often utilized in research aimed at synthesizing other complex molecules. It serves as an important building block in organic synthesis and the design of new materials.
- Analytical Chemistry: The compound's distinct functional groups make it an interesting target for analytical methods. Techniques such as NMR spectroscopy and mass spectrometry can be used to study its structure and behavior in different environments.
As the field of chemistry evolves, compounds like 3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one continue to challenge scientists and inspire new discoveries. Its multifaceted nature exemplifies the intricate relationship between chemical structure and biological function, making it an exciting subject of study.
Synonyms
rofecoxib
162011-90-7
Vioxx
Ceoxx
MK 966
4-(4-(Methylsulfonyl)phenyl)-3-phenylfuran-2(5H)-one
refecoxib
Vioxx Dolor
MK-966
4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone
4-[4-(methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one
MK0966
MK 0966
MK-0966
rofecoxibum
CCRIS 8967
HSDB 7262
TRM-201
UNII-0QTW8Z7MCR
0QTW8Z7MCR
3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one
2(5H)-Furanone, 4-[4-(methylsulfonyl)phenyl]-3-phenyl-
NSC-720256
NSC-758705
CHEBI:8887
DTXSID2023567
M01AH02
MK966
3-phenyl-4-[4-(methylsulfonyl)phenyl]-2(5H)-furanone
4-(4-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone
4-(p-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone
3-Phenyl-4-(4-(methylsulfonyl)phenyl))-2(5H)-furanone
4-(4-methanesulfonylphenyl)-3-phenyl-2,5-dihydrofuran-2-one
CHEMBL122
4-(4-methylsulfonylphenyl)-3-phenyl-5H-furan-2-one
DTXCID903567
TRM201
NSC720256
NSC 720256
NSC 758705
2(5H)-Furanone, 4-(4-(methylsulfonyl)phenyl)-3-phenyl-
NCGC00095118-01
Vioxx-d5 (Major)
ROFECOXIB (MART.)
ROFECOXIB [MART.]
Vioxx (trademark)
SMR000466331
Vioxx (TN)
SR-01000762904
3-phenyl-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone
Rofecoxib (JAN/USAN/INN)
Rofecoxib [USAN:INN:BAN]
Rofecoxib (Vioxx)
Rofecoxib [USAN]
MFCD00935806
Rofecoxib (Standard)
KS-1107
MK 0996
Spectrum_000119
ROFECOXIB [INN]
ROFECOXIB [JAN]
SpecPlus_000669
ROFECOXIB [MI]
ROFECOXIB [HSDB]
Spectrum2_000446
Spectrum3_001153
Spectrum4_000631
Spectrum5_001598
ROFECOXIB [VANDF]
ROFECOXIB [WHO-DD]
SCHEMBL3050
BSPBio_002705
KBioGR_001242
KBioGR_002345
KBioSS_000559
KBioSS_002348
MLS000759440
MLS001165770
MLS001195623
MLS001424113
MLS006010091
BIDD:GT0399
DivK1c_006765
SPECTRUM1504235
Rofecoxib - Bio-X trade mark
SPBio_000492
3-(4-methanesulfonylphenyl)-2-phenyl-2-buten-4-olide
GTPL2893
ROFECOXIB [ORANGE BOOK]
BDBM22369
KBio1_001709
KBio2_000559
KBio2_002345
KBio2_003127
KBio2_004913
KBio2_005695
KBio2_007481
KBio3_002205
KBio3_002825
EX-A708
cMAP_000024
HMS1922H11
HMS2051G16
HMS2089H20
HMS2093E04
HMS2232G21
HMS3371P11
HMS3393G16
HMS3651F16
HMS3713B07
HMS3750I17
HMS3885E05
Pharmakon1600-01504235
BCP03619
UWA68493
Tox21_111430
CCG-40253
HY-17372R
NSC758705
s3043
STK635144
AKOS000280931
AB07701
CS-0997
DB00533
FV28711
NC00132
SB19518
NCGC00095118-02
NCGC00095118-03
NCGC00095118-04
NCGC00095118-05
NCGC00095118-08
NCGC00095118-17
NCGC00095118-18
AC-28318
BR164362
HY-17372
NCI60_041175
SBI-0206774.P001
CAS-162011-90-7
NS00003940
R0206
SW219668-1
C07590
D00568
AB00052090-06
AB00052090-08
AB00052090_09
AB00052090_10
EN300-7364304
L000912
Q411412
SR-01000762904-3
SR-01000762904-5
BRD-K21733600-001-02-6
BRD-K21733600-001-06-7
BRD-K21733600-001-14-1
BRD-K21733600-001-15-8
BRD-K21733600-001-19-0
BRD-K21733600-001-23-2
BRD-K21733600-001-24-0
3-(4-methanesulfonyl-phenyl)-2-phenyl-2-buten-4-olide
4-(4'-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone
Z2037279770
2(5H)-Furanone, 4-[4-(methyl-sulfonyl)phenyl]-3-phenyl-
3-(Phenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone
3-Phenyl-4-(4-(Methylsulfonyl)Phenyl)-2-(5H)-Furanone
4-(4-METHANESULFONYL-PHENYL)-3-PHENYL-5H-FURAN-2-ONE
4-(4-methylsulfonylphenyl)-3-phenyl-2,5-dihydro-2-furanone
4-4-(Methylsulfonyl)phenyl-3-phenyl-2(5H)-furanone;Rofecoxib
Solubility of 3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one
The solubility characteristics of the compound 3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one (C17H14O4S) can greatly influence its applications in various fields, especially in pharmaceuticals and material sciences. Here are some key points regarding its solubility:
In summary, while specific quantitative solubility data may not be readily available, it can be anticipated that 3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one is soluble in a range of organic solvents, which is essential to consider during experimental procedures or in industrial applications.